Relationship between glucocorticoid dose and adverse events in systemic lupus erythematosus: data from a randomized clinical trial. (Record no. 27518822)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01397 a2200373 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517172216.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201804s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1502-7732 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1080/03009742.2017.1336570 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Emamikia, S |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180402 |
| 245 00 - TITLE STATEMENT | |
| Title | Relationship between glucocorticoid dose and adverse events in systemic lupus erythematosus: data from a randomized clinical trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Scandinavian journal of rheumatology |
| Date of publication, distribution, etc. | Mar 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 131-140 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Glucocorticoids |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunosuppressive Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lupus Erythematosus, Systemic |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gentline, C |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Chatzidionysiou, K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Arnaud, L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Vollenhoven, R |
| 773 0# - HOST ITEM ENTRY | |
| Title | Scandinavian journal of rheumatology |
| Related parts | vol. 47 |
| -- | no. 2 |
| -- | p. 131-140 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1080/03009742.2017.1336570">https://doi.org/10.1080/03009742.2017.1336570</a> |
| Public note | Available from publisher's website |
No items available.